| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Chest, Vol 101, 642-648, Copyright © 1992 by American College of Chest Physicians
ARTICLES |
I Annesi, MP Oryszczyn, C Frette, F Neukirch, E Orvoen-Frija and F Kauffmann
Institut National de la Sante et de la Recherche Medicale, Epidemiological Research Unit Villejuif, France.
Epidemiologic data relating total circulating immunoglobulin E (IgE), an objective marker of allergy, to cross-sectional and longitudinal FEV1 as well as to methacholine bronchial hyperresponsiveness were obtained from 310 French adult men surveyed five years apart. Skin prick test responses to common aeroallergens, IgE level, and bronchial hyperresponsiveness were assessed at the end of the follow-up. IgE level was not associated with PD20 to methacholine. Cross-sectionally, age and height-adjusted FEV1 score was inversely related to total IgE level (regression coefficient of FEV1 score on Log[IgE] beta = -.20; p = 0.02). Stratified analysis showed that IgE level was associated with FEV1 score only in nonsmokers (beta = -0.52; p less than 0.001), an association that remained after exclusion of asthmatics. Longitudinally, five-year FEV1 decline was related to IgE in nonsmokers (regression coefficient of FEV1 decline on Log[IgE] beta = 19.9; p = 0.03) and exsmokers (beta = 18.9; p = 0.06) but not in current smokers. The relationship persisted, even if with lesser significance, among exsmokers after exclusion of asthmatics (beta = 17.2) and further exclusion of skin prick test-positive men (beta = 18.8). Whether IgE production also reflects factors other than allergy, possibly nonallergic inflammation, needs further investigations.
This article has been cited by other articles:
|
|
 |
|
  D. S. Postma and H. M. Boezen Rationale for the Dutch Hypothesis: Allergy and Airway Hyperresponsiveness as Genetic Factors and Their Interaction With Environment in the Development of Asthma and COPD Chest, August 1, 2004; 126(2_suppl_1): 96S - 104S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L Portengen, A Hollander, G Doekes, G de Meer, and D Heederik Lung function decline in laboratory animal workers: the role of sensitisation and exposure Occup. Environ. Med., November 1, 2003; 60(11): 870 - 875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Baldacci, E. Omenaas, and M.P. Oryszczyn Allergy markers in respiratory epidemiology Eur. Respir. J., April 1, 2001; 17(4): 773 - 790. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. GREMBIALE, L. CAMPOROTA, S. NATY, C. M. E. TRANFA, R. DJUKANOVIC, and S. A. MARSICO Effects of Specific Immunotherapy in Allergic Rhinitic Individuals with Bronchial Hyperresponsiveness Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2048 - 2052. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Sunyer, J. Soriano, J. M Anto, F. Burgos, A. Pereira, F. Payo, and J. Martinez-Moratalla Sensitization to individual allergens as risk factors for lower FEV1 in young adults Int. J. Epidemiol., February 1, 2000; 29(1): 125 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. EDEN, D. MITCHELL, B. MEHLMAN, H. KHOULI, M. NEJAT, M. H. GRIECO, and G. M. TURINO Atopy, Asthma, and Emphysema in Patients with Severe alpha -1-Antitrypysin Deficiency Am. J. Respir. Crit. Care Med., July 1, 1997; 156(1): 68 - 74. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
